NDC 50090-7661-01 - Sertraline Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-7661
- Requested NDC
- 50090-7661-01
- Package NDCs from labels
- 50090-7661-0, 50090-7661-3, 50090-7661-1, 50090-7661-2, 50090-7661-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-09-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sertraline Hydrochloride - A-S Medication Solutions | A-S Medication Solutions | 2026-09-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-7661-0 | Sertraline Hydrochloride | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 11 | |
| 50090-7661-1 | Sertraline Hydrochloride | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 11 | |
| 50090-7661-2 | Sertraline Hydrochloride | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 11 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-7661-0 | EA - Each | 50090-7661 | 1864a33d-0704-4112-90cb-35ea7f993163 | 1 | 2025-12-16 |
| 50090-7661-1 | EA - Each | 50090-7661 | 7109197e-cb65-43a4-a260-0c99cf3b8ba0 | 1 | 2025-12-16 |
| 50090-7661-2 | EA - Each | 50090-7661 | a8c6b4fe-d95d-473e-9b53-ea338bb1173b | 1 | 2025-12-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mivara Mini | MIVARA MINI | Oncora Pharma, LLC | 16ac821c-b18f-4dbc-a8d8-f10b3862ab45 | 2026-10-26 | Warnings, Adverse reactions | PQ6CK8PD0R |
| HERA SILKYSTAY FOUNDATION 13N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb19976-6983-3d9e-e063-6394a90a01ee | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 17C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb338c7-e99c-887d-e063-6394a90a977c | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 17N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb363fe-c2b2-9381-e063-6294a90ad038 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 17W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb39387-7f6b-ce78-e063-6394a90a15ae | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 21C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb3c3ad-8a77-0655-e063-6394a90ae9e0 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 21N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb3ddb5-4e2b-17d4-e063-6394a90aaa55 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 22N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb415b3-b1ba-42b8-e063-6394a90a90d7 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 21W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb42062-f298-5186-e063-6294a90ab043 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 23C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb44e1b-b24b-6c83-e063-6394a90a4b52 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 23W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb468db-3c38-922d-e063-6294a90adef8 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 24N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb4b8ca-eced-b7ff-e063-6394a90aaefe | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 24O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb4f87a-b4dc-1aa5-e063-6294a90a2ec4 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 25W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb50784-444e-3bf3-e063-6294a90aa618 | 2026-10-25 | Warnings | 15FIX9V2JP |
| Sertraline HCl | SERTRALINE HYDROCHLORIDE | Biocon Pharma Inc. | 623b9672-b41e-4ec9-b2cc-f5bb383c39ba | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | UTI8907Y6X |
| PNV-Omega | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM CORBONATE, FERROUS FUMARATE, POTASSIUM IODIDE, MAGNESIUM, DOCONEXENT, ICOSAPENT | Acella Pharmaceuticals, LLC | 735c5531-137f-4cee-8c68-ae121045a8ff | 2026-10-23 | Boxed warning, Adverse reactions | PQ6CK8PD0R |
| Sertraline Hydrochloride | SERTRALINE HYDROCHLORIDE | Cardinal Health 107, LLC | fd8a815e-88b7-4bef-9e32-6dbc735711a3 | 2026-10-22 | Boxed warning, Warnings, Adverse reactions | ANDA077670 312938 312941 UTI8907Y6X |
| Folivex | MULTIVITAMIN | Oncora Pharma, LLC | 98b4a821-c139-4e9b-99c7-6451af6c27ce | 2026-10-22 | Warnings, Adverse reactions | PQ6CK8PD0R |
| KARYNG Complete SPF Sunscreen Medium/Dark | SUNSCREEN | Karyng LLC | 335eee1e-ef1c-41da-e063-6294a90ac273 | 2026-10-20 | Warnings | 15FIX9V2JP |
| KARYNG Complete SPF Sunscreen Light/Medium | SUNSCREEN | Karyng LLC | 33596253-413d-fba3-e063-6394a90a39e4 | 2026-10-19 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.